A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas

Summary

This study is being conducted to help determine whether β-elemene as maintain treatment for complete remission patients of newly diagnosed malignant gliomas following standard treatment, is able to delay tumor growth, or impact how long people with newly diagnosed high-grade glioma.

Timeline

Start

2015-04

Primary completion

2020-04

Completion

2023-05

Drugs

Indications